[Gifographic] 2017 BDO Biotech Briefing

July 2017

Download PDF Version

Rapid changes in healthcare and biotech/pharma – like the transition to value-based care and drug pricing, the rise of technology and increased life expectancy – are driving research and development (R&D) spending.  See that and other trends that BDO uncovered in the 2017 Biotech Briefing, which examines the most recent 10-K SEC filings of companies listed on the NASDAQ Biotechnology Index.